ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
246.20
+0.70 (0.29%)
At close: Oct 21, 2026, 4:00 PM EDT
246.59
+0.39 (0.16%)
Pre-market: Oct 22, 2026, 7:21 AM EDT
ResMed Market Cap
ResMed has a market cap or net worth of $34.63 billion as of October 21, 2026. It is the 716th most valuable company in the world and the 327th biggest in the United States. Its market cap has decreased by 11.79% in one year.
Market Cap
34.63B
Enterprise Value
33.98B
1-Year Change
-11.79%
Global Rank
Country Rank
#327 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, ResMed's market cap has increased from $485.80M to $34.63B, an increase of 7,027.50%. That is a compound annual growth rate of 16.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 35.41B | 0.73% |
| Dec 31, 2025 | 35.16B | 4.73% |
| Dec 31, 2024 | 33.57B | 32.68% |
| Dec 29, 2023 | 25.30B | -17.01% |
| Dec 30, 2022 | 30.49B | -19.68% |
| Dec 31, 2021 | 37.96B | 23.23% |
| Dec 31, 2020 | 30.80B | 38.24% |
| Dec 31, 2019 | 22.28B | 37.32% |
| Dec 31, 2018 | 16.23B | 35.02% |
| Dec 29, 2017 | 12.02B | 37.39% |
| Dec 30, 2016 | 8.75B | 16.66% |
| Dec 31, 2015 | 7.50B | -4.09% |
| Dec 31, 2014 | 7.82B | 16.86% |
| Dec 31, 2013 | 6.69B | 12.47% |
| Dec 31, 2012 | 5.95B | 40.80% |
| Dec 30, 2011 | 4.22B | -19.35% |
| Dec 31, 2010 | 5.24B | 33.67% |
| Dec 31, 2009 | 3.92B | 38.11% |
| Dec 31, 2008 | 2.84B | -30.14% |
| Dec 31, 2007 | 4.06B | 8.50% |
| Dec 29, 2006 | 3.74B | 38.30% |
| Dec 30, 2005 | 2.71B | 56.41% |
| Dec 31, 2004 | 1.73B | 22.93% |
| Dec 31, 2003 | 1.41B | 39.73% |
| Dec 31, 2002 | 1.01B | -41.47% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Becton, Dickinson and Company | 52.94B |
| Medline | 46.42B |
| Alcon | 32.77B |
| West Pharmaceutical Services | 27.69B |
| Solventum | 14.75B |
| Baxter International | 12.77B |
| Avantor | 11.67B |
| The Cooper Companies | 11.21B |